image
Agios Pharmaceuticals, Inc. AGIO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 53.78
-2.92 %
$ 3.07 B
Market Cap
4.61
P/E
BALANCE SHEET
937 M ASSETS
-24.35%
Growth Rates
1Year -24.35%
3Years 3.19%
5Years 1.77%
7Years 6.10%
10Years 16.63%
126 M LIABILITIES
-8.56%
Growth Rates
1Year -8.56%
3Years -34.73%
5Years -5.90%
7Years -9.85%
10Years 6.10%
811 M EQUITY
-26.33%
Growth Rates
1Year -26.33%
3Years 26.62%
5Years 3.36%
7Years 12.37%
10Years 19.95%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Agios Pharmaceuticals, Inc.
image
Current Assets 834 M
Cash & Short-Term Investments 777 M
Receivables 2.81 M
Other Current Assets 54.1 M
Non-Current Assets 103 M
Long-Term Investments 29.4 M
PP&E 69.8 M
Other Non-Current Assets 4.06 M
Current Liabilities 68 M
Accounts Payable 9.78 M
Short-Term Debt 30 M
Other Current Liabilities 28.2 M
Non-Current Liabilities 58.1 M
Long-Term Debt 114 M
Other Non-Current Liabilities -55.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 88.2 139.3 203.1 127.4 80.9 805.4 567.8 573.6 375.9 14.0 71.6 91.3 117.7
Short Term Investments 688.7 643.9 816.9 445.5 483.9 514.8 321.2 380.6 245.2 328.0 95.2 36.7 61.5
Receivables 2.8 2.2 4.4 0 15.3 10.4 3.7 8.3 11.6 12.7 0.5 0 0
Inventory 19.1 8.5 16.2 14.7 7.3 0.9 (143.8) (32.2) (58.9) 1 0 0 0
Other Current Assets 35.0 39.0 39.8 49.0 24.2 34.3 17.7 10.3 8.7 4.8 5.0 3.1 11.4
Total Current Assets 833.8 832.8 1 064.2 636.7 611.7 613.8 445.3 559.9 337.3 359.5 169.7 130.1 190.6
PP&E 69.8 88.1 104.2 117.5 126.1 24.3 24.4 25.3 23.2 6.4 3.8 3.6 3.2
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 29.4 313.9 266.4 97.6 152.9 220.1 143.8 32.2 58.9 125.4 27.1 0 0
Other Long Term Assets 4.1 4.0 2.9 1.1 (279.0) 0.2 0.9 1.6 0.6 0.6 0.6 0.6 0.6
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 937.1 1 238.7 1 437.7 853.0 890.7 858.5 614.4 619.1 420.1 491.9 201.2 137.0 194.5
LIABILITIES
Accounts Payable 9.8 18.6 16.7 17.7 21.9 17.9 22.8 17.1 14.7 11.1 3.7 3.3 3.6
Short Term Debt 30.0 13.7 11.2 14.8 13.8 0 0 0 0 0 0 0 0
Other Current Liabilities 28.2 30.4 32.0 61.9 46.2 42.9 34.3 35.4 18.5 10.5 6.7 1.8 1.6
Total Current Liabilities 68.0 62.6 59.8 94.4 92.9 93.5 94.9 88.4 52.9 61.1 36.9 35.1 48.2
Long Term Debt 114.0 72.0 85.9 195.6 213.5 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 (261.3) (50.6) 0 0 0 0 0 0 0 0
Other Liabilities (55.8) 3.3 0 163.5 (106.7) 17.6 18.2 17.8 17.4 3.7 0.2 15 K 33 K
Total Liabilities 126.1 137.9 145.8 453.5 250.2 170.9 238.9 260.5 74.9 67.5 69.7 93.1 131.3
EQUITY
Common Stock 72 K 71 K 71 K 69 K 68 K 58 K 49 K 42 K 38 K 37 K 31 K 3 K 3 K
Retained Earnings (822.6) (470.6) (238.8) (1 843.5) (1 516.1) (1 104.6) (798.1) (483.2) (284.7) (166.9) (113.4) (74.0) (53.9)
Other Accumulative Comprehensive Income/Loss (0.4) (12.5) (1.2) 0.1 0.2 (2.2) (1.4) (0.3) (0.3) 57 K 14 K 2 K 23 K
Total Equity 811.0 1 100.8 1 292.0 399.5 640.5 687.5 375.5 358.6 345.1 424.4 131.5 43.9 63.1
Total Liabilities and Equity 937.1 1 238.7 1 437.7 853.0 890.7 858.5 614.4 619.1 420.1 491.9 201.2 137.0 194.5
SHARES OUTSTANDING
Common Shares Outstanding 55.7 54.8 60.4 69.0 60.0 57.4 46.6 39.1 37.4 33.7 15.4 23.4 23.4